USE OF ALKYLGLYCEROLS FOR PREPARING DRUGS

The present invention relates to the use of a composition that comprises: at least one alkylglycerol; at least one inhibitor of the biosynthesis of polyamines; a carrier lean in biologically "active" polyamines; and optionally at least one antitumor agent; as a combination preparation for...

Full description

Saved in:
Bibliographic Details
Main Authors LEGRAND, ALAIN, BERNARD, DENIAU, ANNE-LAURE, MOULINOUX, JACQUES-PHILIPPE
Format Patent
LanguageEnglish
French
Published 16.12.2010
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The present invention relates to the use of a composition that comprises: at least one alkylglycerol; at least one inhibitor of the biosynthesis of polyamines; a carrier lean in biologically "active" polyamines; and optionally at least one antitumor agent; as a combination preparation for a simultaneous, separated or time-spread use, for making a drug for treating pathologies associated with angiogenesis dysfunction and/or tumor pathologies, wherein the total amount of biologically active polyamines ingested per day by the human or animal to whom said drug is administered does not exceed 30 nanomoles per kcal of ingested product, in particular 25 nanomoles per kcal of ingested product, more particularly 23 nanomoles per kcal of ingested product, and more particularly 20 nanomoles per kcal of ingested product. La présente invention concerne l'utilisation d'une composition contenant : au moins un alkylglycérol; au moins un inhibiteur de la biosynthèse des poIyamines; un excipient appauvri en polyamines biologiquement «actives»; et éventuellement au moins un agent antitumoral, comme préparation de combinaison pour une utilisation simultanée, séparée ou étalée dans le temps, pour la fabrication d'un médicament destiné au traitement de pathologies associées à un dysfonctionnement de l'angiogénèse, et / ou de pathologies tumorales, la quantité totale de polyamines bio logiquement «actives» ingérées par jour par l'homme ou l'animal, auquel le susdit médicament est administré, ne dépassant pas 30 nano moles par kcal de produit ingéré, notamment 25 nano moles par kcal de produit ingéré, notamment 23 nano moles par kcal de produit ingéré, notamment 20 nano moles par kcal de produit ingéré.
AbstractList The present invention relates to the use of a composition that comprises: at least one alkylglycerol; at least one inhibitor of the biosynthesis of polyamines; a carrier lean in biologically "active" polyamines; and optionally at least one antitumor agent; as a combination preparation for a simultaneous, separated or time-spread use, for making a drug for treating pathologies associated with angiogenesis dysfunction and/or tumor pathologies, wherein the total amount of biologically active polyamines ingested per day by the human or animal to whom said drug is administered does not exceed 30 nanomoles per kcal of ingested product, in particular 25 nanomoles per kcal of ingested product, more particularly 23 nanomoles per kcal of ingested product, and more particularly 20 nanomoles per kcal of ingested product. La présente invention concerne l'utilisation d'une composition contenant : au moins un alkylglycérol; au moins un inhibiteur de la biosynthèse des poIyamines; un excipient appauvri en polyamines biologiquement «actives»; et éventuellement au moins un agent antitumoral, comme préparation de combinaison pour une utilisation simultanée, séparée ou étalée dans le temps, pour la fabrication d'un médicament destiné au traitement de pathologies associées à un dysfonctionnement de l'angiogénèse, et / ou de pathologies tumorales, la quantité totale de polyamines bio logiquement «actives» ingérées par jour par l'homme ou l'animal, auquel le susdit médicament est administré, ne dépassant pas 30 nano moles par kcal de produit ingéré, notamment 25 nano moles par kcal de produit ingéré, notamment 23 nano moles par kcal de produit ingéré, notamment 20 nano moles par kcal de produit ingéré.
Author DENIAU, ANNE-LAURE
LEGRAND, ALAIN, BERNARD
MOULINOUX, JACQUES-PHILIPPE
Author_xml – fullname: LEGRAND, ALAIN, BERNARD
– fullname: DENIAU, ANNE-LAURE
– fullname: MOULINOUX, JACQUES-PHILIPPE
BookMark eNrjYmDJy89L5WTQDA12VfB3U3D08Y70cfeJdHYN8vcJVnDzD1IICHINcAzy9HNXcAkKdQ_mYWBNS8wpTuWF0twMym6uIc4euqkF-fGpxQWJyal5qSXx4f5GBoYGhiZGlkamjobGxKkCALlwJxk
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
DocumentTitleAlternate UTILISATION D'ALKYLGLYCEROLS POUR LA PREPARATION DE MEDICAMENTS
ExternalDocumentID WO2010142925A1
GroupedDBID EVB
ID FETCH-epo_espacenet_WO2010142925A13
IEDL.DBID EVB
IngestDate Fri Jul 19 15:03:41 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
French
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_WO2010142925A13
Notes Application Number: WO2010FR51171
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20101216&DB=EPODOC&CC=WO&NR=2010142925A1
ParticipantIDs epo_espacenet_WO2010142925A1
PublicationCentury 2000
PublicationDate 20101216
PublicationDateYYYYMMDD 2010-12-16
PublicationDate_xml – month: 12
  year: 2010
  text: 20101216
  day: 16
PublicationDecade 2010
PublicationYear 2010
RelatedCompanies DENIAU, ANNE-LAURE
LEGRAND, ALAIN, BERNARD
NUTRIALYS MEDICAL NUTRITION SA
MOULINOUX, JACQUES-PHILIPPE
UNIVERSITE DE RENNES 1
RelatedCompanies_xml – name: UNIVERSITE DE RENNES 1
– name: MOULINOUX, JACQUES-PHILIPPE
– name: LEGRAND, ALAIN, BERNARD
– name: DENIAU, ANNE-LAURE
– name: NUTRIALYS MEDICAL NUTRITION SA
Score 2.6670916
Snippet The present invention relates to the use of a composition that comprises: at least one alkylglycerol; at least one inhibitor of the biosynthesis of polyamines;...
SourceID epo
SourceType Open Access Repository
SubjectTerms HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title USE OF ALKYLGLYCEROLS FOR PREPARING DRUGS
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20101216&DB=EPODOC&locale=&CC=WO&NR=2010142925A1
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQMQSmgxSzJANdQ2BbXNckzchE1yLF0FLX3NgcWLulmiQnGYA2J_v6mXmEmnhFmEYwMeTA9sKAzwktBx-OCMxRycD8XgIurwsQg1gu4LWVxfpJmUChfHu3EFsXNWjvGHRYlaGZmouTrWuAv4u_s5qzM7DfpuYXBJEDXc1k6gjsK7ECG9LmoPzgGuYE2pdSgFypuAkysAUAzcsrEWJgSisSZuB0ht29JszA4Qud8gYyobmvWIRBMzTYVcHfTcHRxzvSx90n0tk1yN8nWAHYj1MABmSAI2hhg4JLUKh7sCiDsptriLOHLtDOeLgX48P9kR1oLMbAAuz8p0owKCQaWKYAc0ZSciKw32SSnGZhnpSaYpIM7EsmphkZJ1lIMsjgM0kKv7Q0A5cRdHmGoZkMA0tJUWmqLLCSLUmSA4cNAOpFeqk
link.rule.ids 230,309,783,888,25576,76882
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1ZS8NAEB5KFeubVsVq1YAS8CHYHE3ShyJpjkabixzaPoVsDhBESxvx7zuJqfapb8suzO4OOzvz7c4BcMfiOchEMmBYtMUZoeAERs7YESPxEmq3XEjJoApOth3RjITn-XDegvdNLEydJ_S7To6IEpWivJf1fb38f8TSat_K9QN5w67PRyMca3SDjqtkVaxIa5Ox7rmaq9KqiriNdvzfsao001BBrLSHRrZc1TvQXyZVXMpyW6kYR7DvIb2P8hhaxaoLHXVTe60LB3bz5Y3NRvrWJ3AfBTrlGpRizRbW1Fqouu9aAYU4jkJGekrl2EBpfjQNTuHW0EPVZHDO-G-L8au7vUD-DNoI_vNzoJLBKEPJIGmCuElIC1kieSakiCWTguOJ3IP-LkoXu4dvoGOGthVbT87sEg65xlWDFfvQLldf-RUq3JJc13z6AdKtfZk
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=USE+OF+ALKYLGLYCEROLS+FOR+PREPARING+DRUGS&rft.inventor=LEGRAND%2C+ALAIN%2C+BERNARD&rft.inventor=DENIAU%2C+ANNE-LAURE&rft.inventor=MOULINOUX%2C+JACQUES-PHILIPPE&rft.date=2010-12-16&rft.externalDBID=A1&rft.externalDocID=WO2010142925A1